“Real-World Experience and Clinical Utility of a Non-Invasive Gene Expression Rule-Out Test for Melanoma and Additional Validation Against High Risk Driver Mutations in BRAF, NRAS and the TERT Promoter”. 2018. SKIN The Journal of Cutaneous Medicine 2 (December): S69. https://doi.org/10.25251/skin.2.supp.69.